<DOC>
	<DOCNO>NCT00648674</DOCNO>
	<brief_summary>Single site clinical study utilize novel technology microarrays identify characterize molecular mechanism Apligraf promote heal venous leg ulcer .</brief_summary>
	<brief_title>A Post-Marketing Clinical Study Apligraf Venous Leg Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Subject noninfected partial fullthickness venous leg ulcer duration four week great adequately respond conventional therapy Stage II III ulcer define IAET/WOCN ulcer classification guide list Appendix IV . Subject female 18 year age old . Subject venous leg ulcer ( target ulcer ) 5 40 cm2 size . Sexually active female must practice medically proven form contraception course study period . Subject legal guardian must read , understood sign institutional review board ( IRB ) approve Informed Consent Form . Subject and/or legal guardian must able willing follow study procedure instruction . Subject whose target ulcer heal 60 % great area post debridement ( applicable ) Baseline Screen ( Visit 1 ) post debridement Day 0 ( Visit 2 ) determine wound tracing . Subjects treat VAC® ( Vacuum Assisted Closure™ ) Therapy . Subject arterial disease determine Ankle Brachial Index ( ABI ) &lt; 0.65 . Subject systemic condition like uncontrolled diabetes mellitus ( glycosylated HbA1C &gt; 12 % ) , cancer ( biopsy confirm active malignancy ) , positive HIV test , disorder ( ) may compromise wound heal . Subjects currently receive , receive time within one month prior entry study , corticosteroid ( &gt; 15 mg/day ) , immunosuppressive agent , radiation therapy , hemodialysis chemotherapy . Anticipated use agent exclude subject entry study . Clinical vasculitis , severe rheumatoid arthritis , collagen vascular disease . Signs symptom cellulitis osteomyelitis . Necrotic avascular ulcer bed . Venous leg ulcer expose bone , tendon fascia . Subject presence recent infection area intend treatment . Known hypersensitivity bovine collagen component Apligraf agarose ship medium . Subject lactate pregnant ( hCG positive determine lab test ) . Subject liver ( ALT/SGPT , ALP , AST/SGOT , bilirubin , Albumin , total protein , LDH ) and/or renal function ( BUN creatinine ) test great 2 x upper limit normal ( ULN ) Albumin &lt; 2.5 mg/dL . Subject enrol wound investigational device study disease within past four week . Subject previously treat target site Apligraf , Dermagraft cell therapy target site . Subject history alcohol substance abuse within previous year , could interfere study compliance inability attend schedule study visit compliance home dressing change . Subject , opinion investigator , reason list , able complete study per protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>